argus

Ajanta Pharma Ltd.

NSE: AJANTPHARMINE031B01049₹43,571 Cr

Timeline

Time (IST)TypeMEventSrc
03 Nov, 03:27 pm—…Ajanta Pharma Ltd - 532331 - Announcement under Regulation 30 (LODR)-Change in Registered Office Addressbse
03 Nov, 01:32 pm—…Ajanta Pharma Limited has informed the Exchange regarding Board meeting held on November 03, 2025.nse
03 Nov, 01:32 pm—…Ajanta Pharma Ltd - 532331 - Corporate Action- Record Date Fixationbse
03 Nov, 01:31 pm—…Ajanta Pharma Ltd - 532331 - Corporate Action-Board approves Dividendbse
03 Nov, 01:30 pm—…Ajanta Pharma Limited has informed the Exchange that Record date for the purpose of Dividend is 10-Nov-2025.nse
03 Nov, 01:26 pm—…Ajanta Pharma Limited has informed the Exchange that Board of Directors at its meeting held on November 03, 2025, declared Interim Dividend of Rs. 28 per equity share.nse
03 Nov, 01:25 pm—…Ajanta Pharma Ltd - 532331 - Unaudited Financial Results For The Quarter And Half Year Ended 30.09.2025bse
03 Nov, 01:24 pm—…Ajanta Pharma Limited has informed the Exchange that Board of Directors at its meeting held on November 03, 2025, declared Interim Dividend of 28 per equity share.nse
03 Nov, 01:21 pm—…Ajanta Pharma Ltd - 532331 - Board Meeting Outcome for Board Meeting Outcomebse
03 Nov, 01:21 pm—…Ajanta Pharma Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025.nse
24 Oct, 10:13 am—…Ajanta Pharma Limited has informed the Exchange that Record date for the purpose of Dividend is 10-Nov-2025.nse
24 Oct, 10:09 am—…Ajanta Pharma Limited has informed the Exchange regarding 'Board to consider declaration of 1st Interim Dividend and Record Date Fixation'.nse
24 Oct, 09:56 am—…Ajanta Pharma Ltd - 532331 - Corporate Action-Board to consider Dividendbse
24 Oct, 09:49 am—…Ajanta Pharma Ltd - 532331 - Update on board meetingbse
08 Oct, 12:41 pm—…Ajanta Pharma Ltd - 532331 - Board Meeting Intimation for Board Meeting Scheduled To Be Held On 3Rd November 2025.bse
08 Oct, 12:17 pm—…AJANTPHARM: Ajanta Pharma Limited has informed the Exchange about Submission of Sustainability Report for FY 2025 prepared as per GRI Standards.nse
03 Oct, 05:17 pm—…Ajanta Pharma Ltd - 532331 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.bse
03 Oct, 03:12 pm—…Ajanta Pharma Ltd - 532331 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.bse
26 Sept, 10:39 am—…Ajanta Pharma Ltd - 532331 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.bse
16 Sept, 10:41 am—…Ajanta Pharma Ltd - 532331 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.bse
10 Sept, 03:02 pm—…Ajanta Pharma Ltd - 532331 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.bse
02 Sept, 09:11 am—…Ajanta Pharma Limited has informed the Exchange about Participation in Investor Conferencense
02 Sept, 09:05 am—…Ajanta Pharma Ltd - 532331 - Participation In Investor Conferencebse